A practical reference on NAD+: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-06-22. Anything still debated is marked as such rather than presented as settled.
Quality control for NAD+ materials typically combines identity, purity, and water content checks. Identity may be confirmed by ultraviolet spectrum, retention time in chromatography, or mass accuracy, while purity is assessed by HPLC peak area or quantitative nuclear magnetic resonance. Residual water and solvents can affect molar calculations and enzyme assays, so Karl Fischer titration or thermogravimetric analysis may be used. Commercial materials vary in grade and counterion form, and published methods should specify the exact salt or hydrate when reporting concentrations. Regulatory status depends on intended use, with research reagents, dietary ingredients, and clinical products treated under different frameworks.
Quantification of NAD+ in biological samples usually relies on separation techniques coupled to sensitive detection. High-performance liquid chromatography with ultraviolet detection can measure the oxidized form by its absorbance near 260 nm, while mass spectrometry provides greater specificity and can distinguish NAD+ from close analogs. Enzymatic cycling assays use coupled dehydrogenase reactions to amplify signal and estimate NAD+ concentrations in cell or tissue extracts. Because NAD+ and NADH interconvert rapidly, sample preparation must quench metabolism quickly and preserve the redox state before analysis.
The stability of NAD+ depends on pH, temperature, light exposure, and the presence of degradative enzymes. Aqueous solutions are generally more stable under mildly acidic to neutral conditions and degrade faster under alkaline conditions or prolonged heat. The solid is hygroscopic and should be stored desiccated, often frozen, and protected from repeated freeze-thaw cycles. In laboratory handling, aliquots reduce repeated temperature changes, and chelating agents may limit metal-catalyzed hydrolysis in some buffers. These practices matter because even small amounts of NADH or hydrolysis products can interfere with quantitative assays.
Biosynthesis of NAD+ starts from nicotinamide, nicotinic acid, or nicotinamide riboside through salvage pathways. A rate-limiting enzyme, nicotinamide phosphoribosyltransferase, converts nicotinamide to nicotinamide mononucleotide. Further coupling with ATP yields NAD+. In mammals, the liver and muscle can synthesize NAD+ from dietary precursors, but tissue levels vary widely. Researchers study these pathways to understand age-related changes, metabolic disorders, and neurodegeneration. Direct causal links between NAD+ decline and disease remain an active area of investigation.
NAD+ is a dinucleotide composed of adenine, ribose, and nicotinamide groups joined by phosphate linkages. It serves as a coenzyme in oxidoreductase reactions, cycling between oxidized NAD+ and reduced NADH. The molecule is water-soluble and occurs in all living cells. Its nicotinamide ring accepts hydride ions during catabolic reactions, linking substrate oxidation to electron transport. This redox couple supports ATP production and helps maintain cytosolic and mitochondrial redox balance in many cell types.
Beyond redox catalysis, NAD+ is a substrate for enzymes that transfer ADP-ribose or remove acetyl groups from proteins. Sirtuins and poly(ADP-ribose) polymerases consume NAD+ and release nicotinamide as a byproduct. These reactions connect cellular energy status to gene regulation, DNA repair, and stress responses. Because NAD+ is used rather than merely recycled in such signaling, its concentration reflects both biosynthesis and consumption. The balance between salvage and de novo synthesis pathways determines available pools in different tissues.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C or lower | Desiccated; avoid repeated freeze-thaw cycles. |
| Typical analytical method | LC-MS or HPLC with UV detection | Absorbance at 260 nm used for concentration estimates. |
| Reduced form absorbance | 340 nm | NADH absorbs at 340 nm; NAD+ does not. |
| Aqueous stability | pH-dependent | Degradation increases with alkaline pH and heat. |
| Purity check | HPLC purity and UV spectrum | Identity confirmed by retention time and absorbance ratio. |
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that cleave the molecule and transfer its ADP-ribose moiety or remove acetyl groups. Sirtuins consume NAD+ during deacetylation, poly(ADP-ribose) polymerases use it in DNA damage responses, and CD38 enzymes hydrolyze it to signaling metabolites. These consumption pathways mean that NAD+ availability can influence gene regulation, DNA repair, and calcium signaling. Cellular NAD+ concentrations decline in some tissues with age in animal models, but whether this decline is a cause or consequence of aging in humans remains an active open question.
Nicotinamide adenine dinucleotide, commonly abbreviated NAD+, is a dinucleotide coenzyme built from an adenine nucleotide and a nicotinamide nucleotide joined by a pyrophosphate linkage. Its oxidized form carries a positive charge on the nicotinamide ring, while the reduced form, NADH, carries a hydride equivalent. The molecule participates in hundreds of oxidoreductase reactions, where it accepts or donates electrons and protons. Because it can cycle between oxidized and reduced states without net consumption, NAD+ functions as a reusable electron carrier rather than a fuel molecule.
In glycolysis, the tricarboxylic acid cycle, and fatty acid oxidation, NAD+ is reduced to NADH at specific dehydrogenase steps. NADH then delivers electrons to the mitochondrial electron transport chain, mainly at complex I, supporting oxidative phosphorylation and ATP production. The balance between NAD+ and NADH, often expressed as a ratio, influences metabolic flux and redox homeostasis in different cellular compartments. Cytosolic and mitochondrial pools are connected but not identical, and their ratios can differ substantially because of compartment-specific enzymes and transport systems.
NAD+ is relatively unstable in aqueous solution, especially at neutral or alkaline pH and at elevated temperatures. It is typically stored dry, protected from light and moisture, and kept cold or frozen for long-term use. Solutions are often prepared fresh or buffered to mildly acidic pH to slow hydrolysis. Repeated freeze-thaw cycles can reduce integrity. Laboratories may verify concentration using ultraviolet absorbance at 259 nm or by enzymatic assay. These handling practices are general laboratory conventions rather than universal rules.
Research on NAD+ often examines changes with age, diet, exercise, and disease states, but causal relationships are difficult to establish. Some studies measure NAD+ levels, while others assess enzyme activity or downstream markers. In the literature, terms such as "NAD+ decline" and "NAD+ boosting" appear in both scientific and commercial contexts, sometimes without precise definitions. Whether changes in measured NAD+ directly produce health effects remains an open question. Results from cells, animals, and humans cannot be assumed to translate directly.
Measuring NAD+ in biological samples requires rapid processing because the compound can degrade or interconvert after collection. Common approaches include enzymatic cycling assays, high-performance liquid chromatography, and mass spectrometry. Each method has different sensitivity, specificity, and susceptibility to interference from related nucleotides. Sample type matters: cultured cells, animal tissues, and human blood present distinct challenges. Reported values can vary widely across laboratories because of differences in extraction, normalization, and analytical platform. Standardization remains an open issue in the field.
Commercial NAD+ is available at research grade, often with purity specifications determined by high-performance liquid chromatography. Certificates of analysis may report water content, residual solvents, and counterion identity. Identity can be confirmed by ultraviolet absorbance near 260 nm, mass spectrometry, or enzymatic activity. Because different salt forms and hydration states exist, researchers should verify that the product matches the intended molecular form. Lot-to-lot variation in purity can affect quantitative assays and should be documented.
Solid NAD+ is usually supplied as a white to off-white powder or lyophilized preparation. It is hygroscopic and should be kept desiccated at low temperature, commonly -20 °C or below for long-term storage. Aqueous solutions are less stable than dry material and are often prepared fresh or stored frozen in aliquots. Light exposure and repeated freeze-thaw cycles can promote degradation, so amber containers and single-use aliquots are preferred. Buffered solutions near neutral pH are generally less stable than acidic or frozen preparations.
Beyond redox chemistry, NAD+ serves as a substrate for enzymes that transfer ADP-ribose or remove acetyl groups. Sirtuins, PARPs, and CD38-family enzymes consume NAD+ and produce nicotinamide and ADP-ribose-related products. These reactions link NAD+ availability to DNA repair, chromatin modification, and cellular signaling. Because the molecule is central to energy metabolism and regulation, changes in its concentration are studied in aging, immunity, and metabolic research. The balance between synthesis and consumption varies by tissue, developmental stage, and physiological state.
In humans, NAD+ can be synthesized from nicotinic acid, nicotinamide, nicotinamide riboside, and tryptophan through overlapping pathways. The salvage pathway recycles nicotinamide back to NAD+ and is often considered a major route in many tissues. Dietary precursors and intracellular recycling both contribute to the pool, but the quantitative importance of each source remains an active research question. NAD+ levels are not uniform across organs or cell compartments. Measurements in blood do not necessarily reflect concentrations inside tissues.
== Diagnosis == The variety in symptoms, overlap with other disorders, and lack of awareness in medical professionals often complicate the diagnosis of coeliac disease by leading to a delay in the diagnosis. A diagnosis may take more than a decade after symptoms develop, and most people with coeliac disease remain undiagnosed. Delays in diagnosis can reduce quality of life, use more medical resources and increase risk of complications associated with the disease. Coeliac disease is diagnosed based on symptoms, blood tests, and biopsies of the small intestine. To make an accurate diagnosis, an individual must be consuming gluten, as the reliability of biopsies and blood tests reduces if a person is on a gluten-free diet. In those who have already reduced their gluten intake, reintroducing gluten (gluten challenge) may be required to reach an accurate diagnosis. Within months of eliminating gluten from one's diet, antibodies associated with coeliac disease decrease, meaning that gluten has to be reintroduced several weeks before diagnostic testing.
== Early life and education == Kennedy was born on November 11, 1962, in Sault Ste. Marie, Michigan. He earned a Bachelor of Science degree in chemistry at the University of Florida in 1984 and a Ph.D. from the University of North Carolina-Chapel Hill (UNC) in 1988 while working under James Jorgenson. He was an NSF post-doctoral fellow at UNC from 1989 to 1991 with R. Mark Wightman.
== Epidemiology == CGD affects about 1 in 200,000 people in the United States, with about 20 new cases diagnosed each year. Chronic granulomatous disease affects all people of all races; however, there is limited information on prevalence outside of the United States. One survey in Sweden reported an incidence of 1 in 220,000 people, while a larger review of studies in Europe suggested a lower rate: 1 in 250,000 people.
Israel airstrikes struck Khiam, Zebqin, Yater, Shebaa, Nabatieh, Bir Kalb, Kfar Kila, Aalma ech Chaab, and Mays al-Jabal, killing a Hezbollah militant and a Amal Movement militant. Another three people were wounded, namely a Hezbollah militant and a Syrian national. An Israeli Navy officer was killed by a malfunctioning missile launched by the Iron Dome on a Dvora-class fast patrol boat off the coast of Nahariya, northern Israel and two others were injured. An Israel drone strike struck Zawtar El Charkiyeh. The Amal movement said one of its fighters from Khiam was killed. Hezbollah confirmed the death of six militants. Departures and arrivals were canceled at Ben Gurion Airport until 10 a.m.; two El Al flights were diverted. The Golan Regional Council instructed residents of the Golan Heights to remain in their shelters. Yoav Gallant declared an "emergency situation" for two days. Representatives of the United States were monitoring the situation. On 8 September, special forces from the Shaldag Unit raided and destroyed an Iranian rocket manufacturing facility beneath a branch of the Syrian Scientific Studies and Research Center in Masyaf, which was used to supply Hezbollah with precision rockets. On 16 September, the Security Cabinet of Israel approved a new war aim of returning evacuated residents to the north of Israel, adding to the goals of destroying Hamas and liberating the hostages.
Transuranic waste (TRUW) as defined by U.S. regulations is, without regard to form or origin, waste that is contaminated with alpha-emitting transuranic radionuclides with half-lives greater than 20 years and concentrations greater than 100 nCi/g (3.7 MBq/kg), excluding high-level waste. Elements that have an atomic number greater than uranium are called transuranic ("beyond uranium"). Because of their long half-lives, TRUW is disposed of more cautiously than either low- or intermediate-level waste. In the United States, it arises mainly from nuclear weapons production, and consists of clothing, tools, rags, residues, debris, and other items contaminated with small amounts of radioactive elements (mainly plutonium). Under U.S. law, transuranic waste is further categorized into "contact-handled" (CH) and "remote-handled" (RH) on the basis of the radiation dose rate measured at the surface of the waste container. CH TRUW has a surface dose rate not greater than 200 mrem per hour (2 mSv/h), whereas RH TRUW has a surface dose rate of 200 mrem/h (2 mSv/h) or greater. CH TRUW does not have the very high radioactivity of high-level waste, nor its high heat generation, but RH TRUW can be highly radioactive, with surface dose rates up to 1,000,000 mrem/h (10,000 mSv/h). The United States currently disposes of TRUW generated from military facilities at the Waste Isolation Pilot Plant (WIPP) in a deep salt formation in New Mexico.
Sources: en.wikipedia.org
Emicerfont (GW-876,008) is a drug developed by GlaxoSmithKline which acts as a CRF-1 antagonist. Corticotropin releasing factor (CRF), also known as Corticotropin releasing hormone, is an endogenous peptide hormone which is released in response to various triggers such as chronic stress, and activates the two corticotropin-releasing hormone receptors: CRF1 and CRF2. This then triggers the release of corticotropin (ACTH), another hormone which is involved in the physiological response to stress. Emicerfont blocks the CRF1 receptor, and so reduces ACTH release. It has been investigated for the treatment of irritable bowel syndrome (IBS) and alcoholism, and while it was not effective enough to be adopted for medical use in these applications, it continues to be used for research, as the role of the CRH-ACTH system in IBS remains poorly understood.
People with hyperthyroidism absorb much more iodine than healthy people, including radioactive iodine, which is easy to measure. A thyroid scan producing images is typically conducted in connection with the uptake test to allow visual examination of the over-functioning gland. Thyroid scintigraphy is a useful test to characterize (distinguish between causes of) hyperthyroidism, and this entity from thyroiditis. This test procedure typically involves two tests performed in connection with each other: an iodine uptake test and a scan (imaging) with a gamma camera. The uptake test involves administering a dose of radioactive iodine (radioiodine), traditionally iodine-131 (131I), and more recently iodine-123 (123I). Iodine-123 may be the preferred radionuclide in some clinics due to its more favorable radiation dosimetry (i.e., less radiation dose to the person per unit administered radioactivity) and a gamma photon energy more amenable to imaging with the gamma camera. For the imaging scan, I-123 is considered an almost ideal isotope of iodine for imaging thyroid tissue and thyroid cancer metastasis. Thyroid scintigraphy should not be performed in those who are pregnant, a thyroid ultrasound with color flow doppler may be obtained as an alternative in these circumstances. Typical administration involves a pill or liquid containing sodium iodide (NaI) taken orally, which contains a small amount of iodine-131, amounting to perhaps less than a grain of salt. A 2-hour fast of no food before and for 1 hour after ingesting the pill is required.
== External links == Anatomy photo: nervous/pns/nerve1/nerve1 - Comparative Organology at University of California, Davis - "PNS, nerve (LM, Low)" Anatomy photo: nervous/pns/nerve2/nerve1 - Comparative Organology at University of California, Davis - "PNS, nerve (LM, Medium)" Diagram at Howard
For example, polyhydroxymethylene films obtained by alkaline hydrolysis of polyvinylene carbonate films via sodium methoxide in methanol are crystalline and exhibit high tensile strengths. Analogous to cellulose, polyhydroxymethylene can be dissolved in hot sodium hydroxide solution and converted by crosslinking into a highly swellable polymer which can take up to 10,000 times its weight in water. Polyhydroxymethylene is soluble in anhydrous hydrazine and can be converted into cellulose-like fibers by spinning in water. Similar to cellulose, polyhydroxymethylene reacts with carbon disulfide in the alkaline state to form a xanthate, from which water-insoluble polyhydroxymethylene is again obtained by precipitation in dilute sulfuric acid.
The recommended daily intakes for children aged three years and older is 10% to 20% higher than adult levels and those for infants can be as much as 150% higher in the first year of life. Cysteine (or sulfur-containing amino acids), tyrosine (or aromatic amino acids), and arginine are always required by infants and growing children. Methionine and cysteine are grouped together because one of them can be synthesized from the other using the enzyme methionine S-methyltransferase and the catalyst methionine synthase. Phenylalanine and tyrosine are grouped together because tyrosine can be synthesized from phenylalanine using the enzyme phenylalanine hydroxylase.
Sources: en.wikipedia.org
Common methods include LC-MS, HPLC with UV detection, and enzymatic cycling assays. Rapid quenching is needed because NAD+ and NADH interconvert. The chosen method should be validated for the sample matrix.
Solid NAD+ is typically stored desiccated at -20 °C or lower. Aqueous solutions are less stable and should be prepared fresh or frozen in aliquots. Repeated freeze-thaw cycles can reduce integrity.
NADH, NAD+ analogs, hydrolysis products, and residual solvents can interfere. Buffer pH and metal ions may also affect stability or enzyme activity. Blank controls and calibration curves help identify such problems.
NAD+ is the oxidized form and NADH is the reduced form of the same coenzyme. NAD+ accepts electrons during oxidation reactions, becoming NADH, which can donate electrons in other reactions. The ratio between them helps describe a cell's redox state.